Abstract. Random-effects meta-analyses have been widely applied in evidence synthesis for various types of medical studies to adequately address between-studies heterogeneity. However, standard inference methods for average treatment effects (e.g., restricted maximum likelihood estimation) usually underestimate statistical errors and possibly provide highly overconfident results under realistic situations; for instance, coverage probabilities of confidence intervals can be substantially below the nominal level. The main reason is that these inference methods rely on large sample approximations even though the number of synthesized studies is usually small or moderate in practice. In this article we solve this problem using a unified inference method based on the Monte Carlo conditioning method for broad application to random-effects meta-analysis. The developed method provides accurate confidence intervals with coverage probabilities that are almost the same as the nominal level. As specific applications, we provide accurate inference procedures for three types of metaanalysis: conventional univariate meta-analysis for pairwise treatment comparisons, meta-analysis of diagnostic test accuracy, and multiple treatment comparisons via network meta-analysis. We also illustrate the practical effectiveness of these methods via real data applications.
Introduction
In evidence-based medicine, meta-analysis has been an essential tool for quantitatively summarizing multiple studies and producing integrated evidence. In general, the treatment effects from different sources of evidence are heterogeneous due to various factors such as study designs, participating subjects, and treatment administration. Therefore, such heterogeneity should be adequately addressed when combining evidence sources, otherwise statistical errors may be seriously underestimated and possibly result in misleading conclusions (Higgins and Green, 2011) . The randomeffects model has been widely used to address these heterogeneities in most medical meta-analyses. The applications cover various types of systematic reviews, for example, conventional univariate meta-analysis (DerSimonian and Laird, 1986; Whitehead and Whitehead, 1991), meta-analysis of diagnostic test accuracy (Reitsuma et al., 2005) , network meta-analysis for comparing the effectiveness of multiple treatments (Salanti, 2012) , and individual participant meta-analysis (Riley et al., 2010 ).
However, in random effect meta-analysis, most existing standard inference methods for average treatment effect parameters underestimate statistical errors under realistic situations of medical meta-analysis, for example, the coverage probabilities of standard inference methods are usually smaller than the nominal confidence levels, even when the model is completely specified (Brockwell and Gordon, 2001; .
This may lead to highly overconfident conclusions. The main reason for this notable problem is that random-effects models typically include heterogeneity variancecovariance parameters other than the average treatment effect, and most inference methods depend on large sample approximations for the number of trials to be synthesized, which is usually small or moderate in medical meta-analysis. In other words, the variability of the estimation of nuisance parameters is possibly ignored and the total statistical error can be underestimated when constructing confidence intervals.
Recently, several confidence intervals that aim to improve the undercoverage prop- Guolo (2012) , and Sidik and Jonkman (2002) . Although coverage properties are relatively improved under realistic situations, the validity of these methods is substantially guaranteed using large sample approximations. Moreover, most of these methods were developed in the context of traditional direct pairwise comparisons; therefore, the methods have limited applicability in recent, more advanced types of meta-analysis that use the complicated multivariate models noted above.
In this paper, we develop a unified method for constructing accurate confidence intervals for random effect models so that their coverage probabilities would equal to the nominal level regardless of the number of studies. To effectively circumvent the effects of nuisance parameters, we consider the likelihood ratio test (LRT) for the average treatment effect, and we define its p-value based on the conditional distribution given the maximum likelihood estimator of the nuisance parameters rather than the unconditional distribution of the test statistic. For computing the p-value, we adopt the Monte Carlo conditioning technique proposed by Lindqvist and Taraldsen (2005) , and the confidence interval can be derived by inverting the LRT. As a result, the derived confidence intervals are shown to have accurate coverage probabilities and the proposed method can be generally applied to various types of meta-analysis involving complicated multivariate random effect models.
In Section 2, we first provide an algorithm for computing the p-value of the LRT and derive an accurate confidence interval under general statistical models. In Section 3, the proposed method is applied to the simplest univariate random-effects meta-analysis for direct pairwise comparisons. We conduct simulations for evaluating the empirical performances of the proposed confidence interval, and illustrate our method using the well-known meta-analysis of intravenous magnesium for suspected acute myocardial infarction (Teo et al., 1991) . In Sections 4 and 5, we discuss the applications to meta-analysis for diagnostic test accuracy and network meta-analysis, respectively, with illustrations using real datasets. Discussion is provided in Section 6.
We suppose y 1 , . . . , y n are independent and each has the density or probability mass function f i (y i ; φ, ψ) with parameter of interest φ and nuisance parameter ψ. For example, in the univariate meta-analysis described in Section 3, n and y i correspond to the number of studies and estimated treatment effect in the ith study, respectively, and we use the model y i ∼ N (µ, τ 2 + σ 2 i ) with known σ 2 i to estimate the average treatment effect µ, so that φ = µ and ψ = τ 2 in this case. In general, y i , φ and ψ could be multivariate, but we assume in this section that all of them are one-dimensional in order to make our presentation simpler. Multivariate cases are considered in Sections 4 and 5. The likelihood ratio test (LRT) statistic for testing null hypothesis
where
function. Under some regularity conditions, the asymptotic distribution of
under H 0 is χ 2 (1) as n → ∞. However, when the sample size n is not large as is often the case in meta-analysis, the approximation is not accurate enough. The main reason is that there is an unknown nuisance parameter ψ and its estimation error is not ignorable when n is not large. To overcome this problem, we calculate the p-value 
where L ψ = ∂L/∂ψ is the partial derivative of the likelihood function L with respect to the nuisance parameter ψ. Under H 0 , Y can be expressed as Y = H(U, φ 0 , ψ); thereby, the above equation can be rewritten as
We define ψ * (U ) as the solution of the above equation with respect to ψ. Using the result in Lindqvist and Taraldsen (2005) , the p-value E I{T (Y ) ≥ t}| ψ can be expressed as
where the expectation is taken with respect to the distribution of U , and
with some function π(ψ) of ψ. As noted in Lindqvist and Taraldsen (2005) , the choice of π(ψ) controls the efficiency of the Monte Carlo approximation in (1). However, the detailed discussion of this issue would extend of the scope of this paper; thus, we consider in this paper only π(ψ) = 1. The algorithm for computing the p-value for testing H 0 : φ = φ 0 is given as follows. 2. For b = 1, . . . , B with large B, generate a random sample,
3. The Monte Carlo approximation of the p-value is given by
Using the p-value of the LRT of H 0 : φ = φ 0 , the confidence interval of φ with nominal level 1 − α can be constructed as the set of φ † such that the p-value of the LRT of
Although the confidence limits cannot be expressed in closed form, they can be computed by simple numerical methods, for example the bisectional method that repeatedly bisects an interval and selects a subinterval in which a root exists until the process converges numerically, see Section 2 in Burden and Faires (2010). When φ or ψ are multivariate (vector-valued) parameters, this method can be easily extended to the case. When ψ is multivariate, which is typical in many applications, the absolute value symbol in the weight (2) should be recognized as determinant since ∂ ψ/∂ψ is a matrix. On the other hand, when φ is multivariate, we need to construct a confidence region (CR) rather than a confidence interval. In this case, the bisectional method cannot be directly applied, and methods for CRs would depend on each setting. In Section 4, we present a diagnostic meta-analysis in which a CR is traditionally used, and provide a feasible algorithm to compute a CR.
3 Univariate random-effects meta-analysis
The random-effects model
The univariate random-effects model has been widely used in meta-analysis due to its parametric simplicity. However, the accuracy of the inference is poor when the number of studies is small. We consider solving this problem using the LRT and confidence interval introduced in Section 2. We assume that there are n clinical trials and that y 1 , . . . , y n are the estimated treatment effects. We consider the random-effect model:
where θ i is the true effect size of the ith study, and µ is the average treatment effect.
Here e i and ε i are independent error terms within and across studies, respectively, assumed to be distributed as e i ∼ N (0, σ 2 i ) and
The within-studies variances σ 2 i s are usually assumed to be known and fixed to their valid estimates cal-culated from each study. On the other hand, the across variance τ 2 is an unknown parameter representing the heterogeneity between studies. Under these settings, Hardy and Thompson (1996) considered the likelihood-based approach for estimating the average treatment effect µ.
Exact confidence intervals of model parameters
We first consider a confidence interval of µ by using Algorithm 1 in the previous section. To begin with, we consider the null hypothesis H 0 : µ = µ 0 with nuisance (4), the LRT statistic can be defined as
The minimization can be achieved in standard ways such as the iterative method in Hardy and Thompson (1996) .
From (5), the constrained maximum likelihood estimator τ 2 c of τ 2 under H 0 satisfies the following equation:
Let u 1 , . . . , u m be random variables that which independently follow N (0, 1), then y i can be expressed as y i = µ 0 + u i τ 2 + σ 2 i under H 0 . Substituting the expression for y i in the above equation, we have
where U = (u, . . . , u n ) t . The above equation can be easily solved with respect to τ 2 and the solution is given by
Regarding the weight (2), using the implicit function theorem, it holds that
, and thereby we can compute the p-value of the LRT for H 0 : µ = µ 0 from Algorithm 1, and the confidence interval of µ by inverting the LRT.
A confidence interval of τ 2 can be derived as well. By a similar derivation to that for µ, the p-values of the LRT of H 0 : τ 2 = τ 2 0 can be computed from Algorithm 1 with
, and, w(U ) = 1, so that the confidence interval of τ 2 can be similarly constructed.
Simulation study of coverage accuracy
We evaluated the finite sample performances of the proposed confidence interval of µ via Monte Carlo (MC) algorithm together with existing methods widely used in practice. We considered the restricted maximum likelihood (REML) method, the DirSimonian and Laird (DL) method (DirSimonian and Laird, 1986), and the likelihood ratio (LR) method (Hardy and Thompson, 1996) . When implementing the MC method, we used 1000 Monte Carlo samples to compute the p-value. We fixed the true average treatment effect µ at −0.80, and the heterogeneity variance Table 1 , indicate that the confidence intervals from the three methods other than MC are too liberal to achieve the appropriate nominal level 0.95 even when n = 9. On the other hand, the MC method produces reasonable confidence intervals with appropriate coverage probabilities even when n is 3. also applied Peto's fixed effect (PFE) method (Yusuf, 1985) . The results are given in Table 2 . The confidence intervals from the DL, LR, REML, and PFE methods were narrower than that of the MC method since the first four methods cannot adequately account for the additional variability in estimating the between study variance τ 2 . Therefore, the confidence intervals from the first four methods did not cover µ = 1, which does not change the interpretation of the results. On the other hand, the proposed MC method produced a longer confidence interval than the other four methods while also covering µ = 1, that is, the corresponding test for µ = 1 was not significant with a 5% significant level. 
where µ A and µ B are the average logit-transformed sensitivity and specificity, and σ A (> 0) and σ B (> 0) are standard deviations of µ Ai and µ Bi , respectively. Here the parameter ρ ∈ (−1, 1) allows correlation between µ Ai and µ Bi . The unknown parameters are µ A , µ B , σ 2 A , σ 2 B and ρ. Let y Ai and y Bi be the observed logit-transformed sensitivity and specificity, and we assume that
For summarizing the results of the meta-analysis, the CR of µ = (µ A , µ B ) t would be more valuable than separate confidence intervals since sensitivity and specificity might be highly correlated. Reitsma et al. (2005) suggested the 100(1 − α)% joint CR for µ as the interior points of the ellipse defined as
where µ A and µ B are the maximum likelihood estimates of µ A and µ B , s A and s B are estimated standard errors of µ A and µ B , respectively, and c α is the square root of the upper 100α% point of the χ 2 distribution with 2 degrees of freedom. The joint CR (8) is approximately valid; specifically, the coverage error converges to 1 − α as the number of studies n goes to infinity. However, when n is not sufficiently large, the coverage error is not negligible, and the region (8) undercovers the true µ.
Exact CR of sensitivity and specificity
We consider a CR of µ under the models (6) and (7) based on the Monte Carlo method given in Section 2. Let ψ = (σ 2 A , σ 2 B , ρ) t be a vector of nuisance parameters, and write Σ(ψ) rather than Σ to clarify the dependence of ψ. From (6) and (7), the LRT statistic of the null hypothesis H 0 : µ = µ 0 is given by
Under H 0 , the constrained maximum likelihood estimator ψ c satisfies the following equations:
Under H 0 , the observed data y i can be expressed as
Then the above equation can be rewritten as which can be carried out via numerical methods (e.g. the bisectional method).
Example: screening test accuracy for alcohol problems
Here we provide a re-analysis of the dataset given in Kriston et For the bivariate summary data, we fitted the bivariate models (6) and (7), and computed 95% CRs of µ based on the approximated CR of the form (8) Figure   1 with a plot of the observed data, summary points µ, and the summary receiver operating curve. The approximate CR is smaller than the proposed CR, which may indicate that the approximation method underestimates the variability of estimating nuisance variance parameters.
5 Network Meta-analysis
Multivariate random-effects model
Suppose there are p treatments in contract to a reference treatment, and let y ir be an estimator of relative treatment effect for the rth treatment in the ith study. We consider the following multivariate random-effects model:
where y i = (y i1 , . . . , y ip ) t , θ i = (θ i1 , . . . , θ ip ) t is a vector of true treatment effects in the ith study, β = (β 1 , . . . , β p ) t is a vector of average treatment effects, and S i is the within-study variance-covariance matrix. Here we focus on the model (9) In network meta-analysis, each study contains only p i (< p) treatments (p i usually ranges from 2 to 5); thereby, several components in y i cannot be defined. When the corresponding treatments are not involved in the ith study, the corresponding components in y i and S i are shrunk to the sub-vector and sub-matrix, respectively, in the model (9) . Moreover, when the references treatment is not involved in the ith study, we can adopt the data argumentation approach of White et al. (2012) , in which a quasi-small data set is added to the reference arm, e.g. 0.001 events for 0.01 patients.
To clarify the setting in which y i and S i are shrunk to the sub-vector and sub-matrix, respectively, we introduce an index a ij ∈ {1, . . . , p}, j = 1, . . . , p i , representing the treatment estimates that are available in the ith study, and define the p-dimensional vector x ij of 0's, excluding the a ij th element that is equal to 1. Moreover, we define X i = (x i1 , . . . , x ip i ) t , and y i and S i are the shrunken p i -dimensional vector and p i × p i matrix of y i and S i , respectively. The model (9) can be rewritten as
Regarding the structure of between study variance Σ, since there are rarely enough studies to identify the unstructured model of Σ, the compound symmetry structure Σ = τ 2 P (0.5) is used in most cases (White, 2015) , where P (ρ) is a matrix with all diagonal elements equal to 1 and all off-diagonal elements equal to ρ.
. . , X n ), and
model (10) can be expressed as the following random-effects model:
where ε ∼ N (0, S) with S = diag(S 1 , . . . , S n ). The unknown parameters in (11) are β and τ 2 . The log-likelihood of the model (11) is given by
where V (τ 2 ) = τ 2 Z{I n ⊗ P (0.5)}Z t + S and ⊗ denotes the Kronecker product. Note that y is an N -dimensional vector and N = n I=1 p i is the total number of comparisons.
Confidence interval of the average treatment effect
In network meta-analysis, we are interested in not only the average treatment effects β 1 , . . . , β p in contrast to the reference treatment, but also the treatment differences
To handle these issues in a unified manner, we focus on the linear combination η = c t β with known vector c. Define a full-rank p × p matrix A such that the first element of Aβ is η. The parameter η is equivalent to β 1 when we use XA −1 instead of X in the model (11) , so that it is sufficient to consider a confidence interval of β 1 .
Define W 1 and W 2 to be N × 1 and N × (p − 1) matrices such that X = (W 1 , W 2 ), and ω = (β 2 , . . . , β p ) t . The model (11) can be rewritten as
We first consider testing of H 0 : β 1 = β 10 , noting that ω and τ 2 are nuisance parameters. The LRT statistics can be defined as
Under H 0 , the constrained maximum likelihood estimator ω c and τ 2 c satisfy the following equations:
where r(β 1 , ω) = y −W 1 β 1 −W 2 ω and Q = Z{I n ⊗P (0.5)}Z t . Under H 0 , it holds that
The equation (13) can be rewritten as
with r(ω, ω c , τ 2 , u) = W 2 (ω − ω c ) + A(τ 2 )u. The solution of the first equation
, ω, τ 2 , u) = 0 with respect to ω is given by
By replacing w with ω * (u, τ 2 ) in the second equation in (14), we obtain the following equation for τ 2 :
, and we define τ 2 * (u) be the solution of the above equation with respect to τ 2 . Hence, the solutions of (14) with respect to ω and τ 2 are given by ω * (u) = ω * (u, τ 2 * (u)) and τ 2 * (u), respectively. Concerning the weight function w(U ), from the implicit function theorem, it follows that
From (14), we have
On the other hand, because derivation of analytical expressions of the partial derivatives with respect to τ 2 or τ 2 c requires tedious algebraic calculation, we can use numerical derivatives instead. Therefore, we can carry out Algorithm 1 in Section 2 to compute the p-value of LRT, and the confidence interval can be obtained as well by inverting the LRT. for prevention of relapse of schizophrenia; this analysis includes 15 trials comparing eight treatments with placebo. In each trial, the outcomes available were the four outcome states at the end of follow-up: relapse, discontinuation of treatment due to intolerable side effects and other reasons, not reaching any of the three endpoints, and still in remission. We here considered the last outcome and adopted the odds ratio as the treatment effect measure.
We applied the multivariate random-effects model (11) with a compound symmetry structure of Σ. The reference treatment was set to "Placebo". The estimates of between-studies standard deviation τ were 0.28 for the ML and 0.52 for the REML estimation methods, respectively, which shows that there is substantial heterogeneity between studies.
In Table 3 we present the results of three confidence intervals based on the MC method, the LR-based method with p-value calculated by the asymptotic distribution, and the REML method. The number of Monte Carlo samples in applying the MC method was consistently set to 20000. In this analysis, the confidence intervals of the MC method were much wider than those of the LR method, and indicated larger uncertainty in the inference of average treatment effects. On the other hand, the confidence intervals of the REML method were wider than those of the MC method in the last three treatments although the REML method produced narrower intervals than the MC method in the first five treatments; this may be due to the difference between the ML and REML estimates of between study standard deviation (0.28 for ML and 0.52 for REML). We developed a unified method for constructing confidence intervals of the average treatment effects in random-effects meta-analysis. The proposed confidence intervals are based on the LRT, and we proposed a Monte Carlo method to compute its p-value.
In terms of specific applications, we discussed three types of meta-analysis, univariate meta-analysis, diagnostic meta-analysis, and network meta-analysis, and demonstrated the usefulness of the proposed method. The developed inference method would be adapted to a variety of applications, e.g., the multivariate individual participant data meta-analysis (Burke et al., 2016) . A limitation of the proposed methods might be rigorous justification of the exactness of the proposed inference methods.
Although the maximum likelihood estimator of the variance parameters are sufficient statistics in the case that all the within-study variances are the same, this property might not hold rigorously, under general conditions. Although there were no theoretical proofs concerning the sufficiency of this estimator under general conditions, but we could clearly demonstrate the proposed methods could provide almost exact confidence intervals in the simulation studies. We guess the sufficiency property would be hold under more general settings, and the theoretical justifications would be one of relevant further issues.
In addition, the numerical results from our simulations and the illustrative examples suggest that statistical methods in the random-effects models should be selected carefully in practice. Historically, there have been many discrepant results between meta-analyses and subsequent large randomized clinical trials (LeLorier et al, 1997), and in these cases the meta-analyses have typically tended to provide false results as in the magnesium example in Section 3.4. Many systematic biases, for example, publication bias (Begg and Berlin, 1988; Easterbrook et al., 1991) , might be important sources of these discrepancies, but we should also be aware of the risk of providing overconfident and misleading interpretations caused by the statistical methods based on large sample approximations. Considering these risks, accurate inference methods would be preferred in practice. Although there have not been any accurate inference methods that can be broadly applied in random-effects meta-analyses, our approach in this article may provide an explicit solution to this relevant problem.
Finally, methodological research on extensions of random-effects meta-analyses to more complicated statistical models are still in progress (e.g., multivariate network meta-analyses, Riley et al., 2017) , and the small sample problems generally exist in most of these applications. Our methods are applicable to these complicated models as well as more advanced approaches that might arise in future research. The developed methods should be effective tools as a unified methodological framework to obtain accurate solutions in medical evidence synthesis.
